loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Nomisma Healthcare? Find (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide to address your drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 397Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Nomisma Healthcare

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
IMCAS Asia
Not Confirmed

02

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank